Abstract
The molecular mechanism of vascular pathology mediated by circulating lipoprotein(a) [Lp(a)] remains unknown. We examined the role of two distinguishing features of Lp(a) viz non-covalent complex formation with a low density lipoprotein (LDL) and heavy glycosylation as determinants of binding of this lipoprotein and its LDL complex to cell-surface receptors. LDL isolated from the Lp(a):LDL complex, free LDL and oxidized LDL were equally efficient in forming a reconstituted complex with pure Lp(a). Complexed LDL in healthy individuals was equal in oxidation status to free LDL. The number of LDL molecules associated with each Lp(a) molecule (LDL index) in plasma samples increased steadily with Lp(a) size (correlation coefficient r = 0.834). Complex reconstituted from purified plasma Lp(a) and LDL maintained the same LDL index as plasma in accordance with Lp(a) size. Consequently, the percentage of complex-free Lp(a) in the plasma decreased sharply with Lp(a) size (r = −0.887). Although O-glycosylation measured in terms of lectin binding increased with Lp(a) size, the LDL index increased significantly faster than O-glycosylation among Lp(a) phenotypes of different plasma samples. Complexes with varying stoichiometry existed in the same plasma. Extra LDL complex molecules were not recognized by LDL receptors on human macrophages or rat cardiac fibroblasts indicating attachment to Lp(a) involved LDL receptor-binding sites. However, unlike free LDL complex LDL could attach through Lp(a) to immobilized form of galectin-1, a lectin ubiquitous on mammalian cells. Results suggest that phenotype-dependence of the physiological and pathological functions of Lp(a) may operate through differential LDL-carrier activity.
Similar content being viewed by others
Abbreviations
- FITC:
-
Fluorescein isothiocyanate
- JL1:
-
Lipid fraction of jacalin precipitate of plasma
- JSL1:
-
Lipid layer of supernatant after jacalin precipitation of plasma
- PBS:
-
20 mM potassium phosphate buffer with150 mM NaCl, pH 7.4
- PBS-T:
-
PBS containing 0.05 % Tween 20
- PEG-6000:
-
Polyethylene glycol-6000
- SDS-PAGE:
-
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
- TBE:
-
Tris Borate EDTA buffer (0.05 M Tris, 0.025 M boric acid, 0.003 M disodium salt of EDTA), pH 8.7
References
Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE (1992) Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem 267:24369–24374
Lawn RM, Boonmark NW, Schwartz K, Lindahl GE, Wade DP, Byrne CD, Fong KJ, Meer K, Patthy L (1995) The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a). J Biol Chem 270:24004–24009
McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132–137
Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH (1991) Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 87:2153–2161
Marcovina SM, Zhang ZH, Gaur VP, Albers JJ (1993) Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 191:1192–1196
Momiyama Y, Ohmori R, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Nagata M, Ohsuzu F (2012) Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis. Atherosclerosis 222:241–244
Smolders B, Lemmens R, Thijs V (2007) Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke 38:1959–1966
Solfrizzi V, Panza F, D’Introno A, Colacicco AM, Capurso C, Basile AM, Capurso A (2002) Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 72:732–736
Pepin JM, O’Neil JA, Hoff HF (1991) Quantification of apo[a] and apoB in human atherosclerotic lesions. J Lipid Res 32:317–327
Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ (1991) Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem 266:5480–5485
Garner B, Merry AH, Royle L, Harvey DJ, Rudd PM, Thillet J (2001) Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance. J Biol Chem 276:22200–22208
Chellan B, Narayani J, Appukuttan PS (2007) Galectin-1, an endogenous lectin produced by arterial cells, binds lipoprotein(a) [Lp(a)] in situ: relevance to atherogenesis. Exp Mol Pathol 83:399–404
Heyderman E, Strudley K, Richardson TC (1989) Immunohistochemistry in pathology. In: Weir DM, Herzanberg LA, Blackwell C, Herzenberg LA (eds) Hand Book of Experimental Immunology. Blackwell, Oxford, pp 129.121–129.127
Anu P, Moly A, Jaisy M, Appukuttan PS (2011) High polymeric IgA content facilitates recognition of microbial polysaccharide-natural serum antibody immune complexes by immobilized human galectin-1. Immunol Lett 136:55–60
Hudson L, Hay FC (1980) Practical immunology. Blackwell, Oxford, pp 11–13
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Anuradha S, Geetha M, Sabari SP, Appukuttan PS (2013) ApoB-independent enzyme immunoassay for lipoprotein(a) by capture on immobilized lectin (jacalin). J Immunoassay Immunochem 34:166–179
Sureshkumar G, Appukuttan PS, Basu D (1982) Purification and characterization of an alpha-galactose binding lectin from jack fruit seed (Artocarpus integrifolia). J Biosci 4:257–261
Sangeetha SR, Appukuttan PS (2005) IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1– > 3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand. Int J Biol Macromol 35:269–276
Chellan B, Appukuttan PS, Jayakumari N (2006) Electroelution of lipoprotein(a) [Lp(a)] from native polyacrylamide gels: a new, simple method to purify Lp(a). J Biochem Biophys Methods 68:43–53
Hudson L, Hay FC (1980) Practical immunology. Blackwell, Oxford, pp 227–228
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Galle J, Mulsch A, Busse R, Bassenge E (1991) Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler and thromb: J Vasc Biol/Am Heart Assoc 11:198–203
Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM (2001) A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 42:1308–1317
Panda SK, Kumar S, Tupperwar NC, Vaidya T, George A, Rath S, Bal V, Ravindran B (2012) Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia. PLoS Pathog 8:e1002717
Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353:46–57
Yashiro A, O’Neil J, Hoff HF (1993) Insoluble complex formation of lipoprotein (a) with low density lipoprotein in the presence of calcium ions. J Biol Chem 268:4709–4715
Mahley RW, Weisgraber KH, Melchior GW, Innerarity TL, Holcombe KS (1980) Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys. Proc Natl Acad Sci USA 77:225–229
Armstrong VW, Walli AK, Seidel D (1985) Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 26:1314–1323
Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P (2001) Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89:1111–1121
Mehta KD, Chen WJ, Goldstein JL, Brown MS (1991) The low density lipoprotein receptor in Xenopus laevis. I. Five domains that resemble the human receptor. J Biol Chem 266:10406–10414
Barondes SH, Cooper DN, Gitt MA, Leffler H (1994) Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269:20807–20810
Nielsen LB, Stender S, Jauhiainen M, Nordestgaard BG (1996) Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. J Clin Invest 98:563–571
Danesh J, Collins R, Peto R (2000) Lipoprotein(a) and coronary heart disease: Meta-analysis of prospective studies. Circulation 102:1082–1085
Guerra R, Yu Z, Marcovina S, Peshock R, Cohen JC, Hobbs HH (2005) Lipoprotein(a) and apolipoprotein(a) isoforms: no association with coronary artery calcification in the Dallas heart study. Circulation 111:1471–1479
Kotani K, Sakane N (2012) Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels. J Clin Med Res 4:130–134
Geetha M, Sabarinath PS, Kalaivani V, Appukuttan PS (2013) Human plasma anti-α-galactoside antibody forms immune complex with autologous lipoprotein(a). Immunol Invest 42:324–340
Geetha M, Kalaivani V, Sabarinath PS, Appukuttan PS (2014) Plasma anti-α-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a). Glycoconj J. doi:10.1007/s10719-014-9521-2
Acknowledgments
The authors are grateful to Dr. Jaisy Mathai, Head, Department of Transfusion Medicine and Dr. Sivakumar, Scientist, Department of Cellular and Molecular Cardiology of this institute for provision of out-dated plasma samples and cultured (75 % confluent P3 passage) rat cardiac fibroblasts, respectively. V. Kalaivani received a fellowship from University Grants Commission (UGC), New Delhi, India.
Conflict of interest
None to be reported.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kalaivani, V., Appukuttan, P.S. Circulating Lp(a):LDL Complexes Contain LDL Molecules Proportionate to Lp(a) Size and Bind to Galectin-1: A Possible Route for LDL Entry into Cells. Lipids 49, 1101–1113 (2014). https://doi.org/10.1007/s11745-014-3941-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-014-3941-4